INOVIQ Ltd (ASX:IIQ)
0.3650
+0.0300 (8.96%)
At close: Mar 18, 2026
INOVIQ Market Cap
INOVIQ has a market cap or net worth of 51.38 million as of March 18, 2026. Its market cap has increased by 3.53% in one year.
Market Cap
51.38M
Enterprise Value
37.85M
Revenue
2.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.37
Market Cap Chart
Since June 20, 2016, INOVIQ's market cap has increased from 13.25M to 51.38M, an increase of 287.86%. That is a compound annual growth rate of 14.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 47.16M | -13.55% |
| Dec 31, 2025 | 54.55M | -5.02% |
| Dec 31, 2024 | 57.44M | -6.14% |
| Dec 29, 2023 | 61.19M | 3.91% |
| Dec 30, 2022 | 58.89M | -46.44% |
| Dec 31, 2021 | 109.96M | 102.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Integral Diagnostics | 856.40M |
| Healius | 417.53M |
| Australian Clinical Labs | 381.75M |
| Monash IVF Group | 245.47M |
| Rhythm Biosciences | 70.57M |
| Cryosite | 58.33M |
| Microba Life Sciences | 48.72M |
| BCAL Diagnostics | 36.87M |